Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

Rubius Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues21.28.4
            Revenue growth152.6% 
Cost of goods sold43.310.9
Gross profit-22.0-2.4
            Gross margin-103.8%-29.1%
General and administrative22.02.4
EBIT-43.3-10.9
            EBIT margin-203.8%-129.1%
Pre-tax income-43.8-11.0
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income0.00.0
            Net margin-0.2%-0.1%
 
Diluted EPS($5.55)($1.63)
Shares outstanding (diluted)0.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy